Opyl's http://Trialkey.ai: Achieving Up to 90% Accuracy in Predicting Drug Clinical Trial Outcomes Unveiling TrialKey's Advanced Data Processing: Leveraging AI for Enhanced Trial Designs and Success Rates.
Craig S. Smith’s Post
More Relevant Posts
-
Opyl's http://Trialkey.ai: Achieving Up to 90% Accuracy in Predicting Drug Clinical Trial Outcomes Unveiling TrialKey's Advanced Data Processing: Leveraging AI for Enhanced Trial Designs and Success Rates.
Opyl's Trialkey.ai: Achieving Up to 90% Accuracy in Predicting Drug Clinical Trial Outcomes
https://www.youtube.com/
To view or add a comment, sign in
-
Reposting this with gratitude and excitement! Thank you for the kind mention—always a pleasure to share insights on the future of healthcare. Check out this fantastic Medhustlr video where we explore how AI is transforming diagnostics, drug development, and primary care. Curious about where AI can take us next? Let’s discuss—drop your thoughts below!
Special Thanks to Dr. Manthan Mehta for his valuable insights about this Industry. Hustlers, the future is here, and it's powered by AI! Imagine a world where: ✅ Diseases are diagnosed faster than ever. ✅ Drug trials are more efficient and accurate. ✅ Primary care is smarter, accessible, and personalized. Sounds like science fiction? Think again! In our latest Medhustlr video, we dive deep into how Artificial Intelligence is transforming the healthcare landscape, reshaping diagnostics, revolutionizing drug development, and making primary care smarter and more efficient. 💡 If you're a healthcare enthusiast, a curious learner, or someone who's ready to embrace the intersection of medicine and technology, this is your cue. 👉 Watch the video now and get ready to explore the possibilities of AI-driven healthcare innovation. 🧠 Question for you, Hustlers: Where do you see the biggest potential for AI in healthcare? Let’s discuss in the comments below! #AIinMedicine #HealthcareInnovation #MedTech #Medhustlr Link for the video:
Future of Healthcare with AI in Diagnostic Medicine, Drug Discovery and Primary Care #medhustlr
https://www.youtube.com/
To view or add a comment, sign in
-
Special Thanks to Dr. Manthan Mehta for his valuable insights about this Industry. Hustlers, the future is here, and it's powered by AI! Imagine a world where: ✅ Diseases are diagnosed faster than ever. ✅ Drug trials are more efficient and accurate. ✅ Primary care is smarter, accessible, and personalized. Sounds like science fiction? Think again! In our latest Medhustlr video, we dive deep into how Artificial Intelligence is transforming the healthcare landscape, reshaping diagnostics, revolutionizing drug development, and making primary care smarter and more efficient. 💡 If you're a healthcare enthusiast, a curious learner, or someone who's ready to embrace the intersection of medicine and technology, this is your cue. 👉 Watch the video now and get ready to explore the possibilities of AI-driven healthcare innovation. 🧠 Question for you, Hustlers: Where do you see the biggest potential for AI in healthcare? Let’s discuss in the comments below! #AIinMedicine #HealthcareInnovation #MedTech #Medhustlr Link for the video:
Future of Healthcare with AI in Diagnostic Medicine, Drug Discovery and Primary Care #medhustlr
https://www.youtube.com/
To view or add a comment, sign in
-
Sixing Huang transforms DrugBot into a highly adaptive, context-aware tool capable of memory retention, complex query generation, and human-in-the-loop interaction. This innovative framework empowers patients and researchers to navigate a comprehensive drug trial database with ease and precision, exemplifying the transformative potential of AI in healthcare and data management. https://lnkd.in/e_2Ajtf3
To view or add a comment, sign in
-
🚀 AI in Clinical Trials: 5 Urgent Facts You Need to Know Right Now in 2024 🤖 AI is revolutionizing clinical trials in ways we never imagined. From accelerating drug development to improving patient recruitment and data accuracy, AI is reshaping the future of healthcare in 2024. Swipe through to discover how AI is cutting trial times, reducing costs, and driving better outcomes! 📊✨ Share Your Thoughts! #AIinHealthcare #ClinicalTrials #InnovationInMedicine #FutureOfHealthcare #PharmaInnovation #ArtificialIntelligence #ClinicalResearch #PatientCentric #HealthcareInnovation #AI2024 #MedTech #Pharma #ClinicalTrialSolutions #DataDriven #HealthTech
To view or add a comment, sign in
-
On today´s International Clinical Trials´ Day, Pivotal focuses on promoting strategies to increase the knowledge and participation of the general population in the drug development life cycle as well as stressing new techs to enhance clinical trials. Pivotal´s brand-new integrated CTMS, eTMF and RBQM tool uses AI and ML to speed up and boost reliability of clinical data. Pivotal Patient Journey #Pivotal #Biotech #ClinicalTrials
To view or add a comment, sign in
-
Patient recruitment is a major bottleneck in clinical trials, often taking months and adding substantial costs to drug development. But artificial intelligence is out to change that! Formation Bio has just launched Muse, an innovative AI tool designed to transform the patient recruitment process in clinical trials, aiming to compress recruitment timelines from months to mere minutes! Here’s a look at how Muse works and what this means for the future of drug development >> bit.ly/4hNBA94 #myAMCR #HeadlandsResearchAMCR #ClinicalTrials #ClinicalResearchProcess #ArtificialIntelligenceTechnology #PowerOfAi #AIandDiabetes
To view or add a comment, sign in
-
Fascinating Healthcare AI Regulatory Questions 1. How do we regulate clinical generative AI that is constantly evolving based on continuous large language model (LLM) input? 2. How do we test for the competence of clinical generative AI if it is viewed as intelligence and not regulated like a pharmaceutical drug or medical device? 3. How do we ensure clinical generative AI remains objective and does not reflect the covert nor overt biases of its owners and LLM data sources? #HealthcareAI #GenerativeAI #Regulation #LLM #DataEvolution #Bias
How to Regulate Generative AI in Health Care
hbr.org
To view or add a comment, sign in
-
The flip side of GLP-1s (Where I take issue with my own views) Employers and others are struggling with coverage and costs, which why is waste is not seriously addressed yet (and why my comment in the earlier post below may look hopelessly naive to some) 1) Drug trends in the employer market are ugly, and coverage of GLP1 doesn’t make it an easier lift. Denial isn’t just a river in Egypt see Adam Fein 2) The effect on long term cost trend is still unknown. As you can see, Denmark’s largest public insurer was not convinced and due to churn, hard for employers especially small ones. 3) The label as I have oft pointed out says exercise and diet AND GLP-1. Employers and others don’t know quite what to do here. How could we spend so much on this and yet know so little? Yes one company says they can maintain an off ramp and provide support but for how long and it’s not an RCT is it? https://lnkd.in/esWZFQFP And the end of the day the cost must come down (and it will as the IRA looks to combine different strengths of the same product) perhaps that is the best point to address waste. I am still a believer in not wasting resources or why cover it at all?
Reduce Waste and (Waist) Most of us are familiar with the Prime Therapeutics study of the very high level of dropped prescriptions for the obseity drugs plus or minus 70 percent drop out (now peer reviewed pub but here is the original link https://lnkd.in/etFUy4ak) Two thoughts on how to reduce the waste 1) sort out the non responders prior to initiation of therapy (about 1 in 7 users are non responsive) ☑️a genetic test developed by Mayo Clinic researchers can predict with 95% accuracy who's likely to lose weight according to a new small study, per CNN. Other studies are under way including the overresponders see https://lnkd.in/e4u_wVHu 2) Cost sharing. Lots of chatter on the large rebates but not so much on financial toxicity even tho that’s one of the reasons patients report for dropping ☑️adjust the cost sharing for the net price. For instance Denmark reports that the dropped rate was 56 percent a sizable difference with about 25 percent reinitiating also lancet https://lnkd.in/edX-BUFK At the end of the day will it be enuf? Ironically Denmarks largest insurer said it would stop reimbursing in 2024 due to the cost https://lnkd.in/eB7v75xK #GLP-1 #reducewaste PS Good lightening round #Axios
Axios Vitals - GLP-1 lightning round
axios.com
To view or add a comment, sign in
-
Reduce Waste and (Waist) Most of us are familiar with the Prime Therapeutics study of the very high level of dropped prescriptions for the obseity drugs plus or minus 70 percent drop out (now peer reviewed pub but here is the original link https://lnkd.in/etFUy4ak) Two thoughts on how to reduce the waste 1) sort out the non responders prior to initiation of therapy (about 1 in 7 users are non responsive) ☑️a genetic test developed by Mayo Clinic researchers can predict with 95% accuracy who's likely to lose weight according to a new small study, per CNN. Other studies are under way including the overresponders see https://lnkd.in/e4u_wVHu 2) Cost sharing. Lots of chatter on the large rebates but not so much on financial toxicity even tho that’s one of the reasons patients report for dropping ☑️adjust the cost sharing for the net price. For instance Denmark reports that the dropped rate was 56 percent a sizable difference with about 25 percent reinitiating also lancet https://lnkd.in/edX-BUFK At the end of the day will it be enuf? Ironically Denmarks largest insurer said it would stop reimbursing in 2024 due to the cost https://lnkd.in/eB7v75xK #GLP-1 #reducewaste PS Good lightening round #Axios
Axios Vitals - GLP-1 lightning round
axios.com
To view or add a comment, sign in